Trial · NCT01903252
Participant flow54
How many started, completed or left each group, period by period.
1 to 20 of 54
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Double-Blind Induction | STARTED | TP05 (Mesalazine) 1600 mg | 409 | |
| Double-Blind Induction | STARTED | Asacol (Mesalazine 400 mg) | 408 | |
| Double-Blind Induction | STARTED | Extended Induction | 0 | |
| Double-Blind Induction | STARTED | 1.6g TP05 (1600 mg) /Day Maintenance Open-Label | 0 | |
| Double-Blind Induction | STARTED | 3.2g TP05 (1600 mg) /Day Maintenance Open-Label | 0 | |
| Double-Blind Induction | STARTED | 4.8g TP05 (1600 mg) /Day Maintenance Open-Label | 0 | |
| Double-Blind Induction | COMPLETED | TP05 (Mesalazine) 1600 mg | 370 | |
| Double-Blind Induction | COMPLETED | Asacol (Mesalazine 400 mg) | 367 | |
| Double-Blind Induction | COMPLETED | Extended Induction | 0 | |
| Double-Blind Induction | COMPLETED | 1.6g TP05 (1600 mg) /Day Maintenance Open-Label | 0 | |
| Double-Blind Induction | COMPLETED | 3.2g TP05 (1600 mg) /Day Maintenance Open-Label | 0 | |
| Double-Blind Induction | COMPLETED | 4.8g TP05 (1600 mg) /Day Maintenance Open-Label | 0 | |
| Double-Blind Induction | NOT COMPLETED | TP05 (Mesalazine) 1600 mg | 39 | |
| Double-Blind Induction | NOT COMPLETED | Asacol (Mesalazine 400 mg) | 41 | |
| Double-Blind Induction | NOT COMPLETED | Extended Induction | 0 | |
| Double-Blind Induction | NOT COMPLETED | 1.6g TP05 (1600 mg) /Day Maintenance Open-Label | 0 | |
| Double-Blind Induction | NOT COMPLETED | 3.2g TP05 (1600 mg) /Day Maintenance Open-Label | 0 | |
| Double-Blind Induction | NOT COMPLETED | 4.8g TP05 (1600 mg) /Day Maintenance Open-Label | 0 | |
| Extended Induction, Open-Label | STARTED | TP05 (Mesalazine) 1600 mg | 0 | |
| Extended Induction, Open-Label | STARTED | Asacol (Mesalazine 400 mg) | 0 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01903252/flow